The Alzheimer disease pathway is the second-ranked signaling pathway, and 5 key targets, CASP9, APP, NOS2, NOS1 and PTGS2, are enriched in this pathway. Here, NOS2 is linked to early-onset autosomal dominant Alzheimer disease.